Aclaris Therapeutics Inc (ACRS)
1.18
-0.01
(-0.84%)
USD |
NASDAQ |
Apr 26, 12:56
Aclaris Therapeutics Gross Profit Margin (Quarterly): 63.41% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 63.41% |
| September 30, 2023 | 11.74% |
| June 30, 2023 | 14.82% |
| March 31, 2023 | 26.07% |
| December 31, 2022 | 80.47% |
| September 30, 2022 | 56.76% |
| June 30, 2022 | 30.10% |
| March 31, 2022 | 20.51% |
| December 31, 2021 | 23.45% |
| September 30, 2021 | 33.76% |
| June 30, 2021 | 30.76% |
| March 31, 2021 | 32.36% |
| December 31, 2020 | 18.61% |
| Date | Value |
|---|---|
| September 30, 2020 | 17.94% |
| June 30, 2020 | 32.11% |
| March 31, 2020 | 9.81% |
| December 31, 2019 | 6.21% |
| September 30, 2019 | 15.97% |
| June 30, 2019 | -12.19% |
| March 31, 2019 | 4.43% |
| December 31, 2018 | 28.56% |
| September 30, 2018 | 4.56% |
| June 30, 2018 | 67.87% |
| March 31, 2018 | 13.51% |
| December 31, 2017 | 24.52% |
| September 30, 2017 | 33.77% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-12.19%
Minimum
Jun 2019
80.47%
Maximum
Dec 2022
26.98%
Average
23.45%
Median
Dec 2021
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -50.99% |
| Return on Assets | -38.95% |
| Return on Invested Capital | -50.99% |
| Profit Margin (Quarterly) | -8.49% |
| Operating Margin (Quarterly) | -135.0% |
| Return on Net Operating Assets | -1.16K% |